Get updates delivered to you daily. Free and customizable.
Axios Raleigh
Japanese biotech company adding 680 additional jobs to under-construction Wake County plant
By Zachery Eanes,
2024-04-11
Fujifilm Diosynth will invest $1.2 billion and create an additional 680 jobs at its under-construction biomanufacturing facility in Holly Springs by 2031, the N.C. Department of Commerce announced Thursday morning.
The Japanese contract drug manufacturer will receive $69.2 million in incentives from the state as well as Wake County and Holly Springs if it meets hiring and investment targets.
Why it matters: The announcement from Fujifilm represents a significant addition to the company's presence in Holly Springs — where in 2021 it pledged to build a $1.5 billion vaccine-and-drugs plant that would create more than 700 jobs.
That facility is expected to be fully operational by next year.
Zoom in: The minimum average salary of the new Fujifilm positions will be $109,000, according to the Commerce Department. New jobs include engineers, scientists, manufacturing personnel, and other support positions.
Fujifilm's investment will include adding two additional drug substance manufacturing buildings, a building with administrative space, and expansions of utilities, lab, and warehouse buildings currently under construction.
The incentives agreement requires Fujifilm to retain 1,389 jobs in Wake County.
Fujifilm also has a large office and manufacturing presence in Research Triangle Park.
The intrigue: The Commerce Department said Holly Springs was competing with locations in Singapore, Denmark and Ventura County, California, for the investment.
Driving the news: The announcement comes ahead of Japanese Prime Minister Fumio Kishida's visit to Raleigh on Thursday and Friday — a trip planned to highlight the growing economic ties between North Carolina and Japan.
The state's Economic Investment Committee approved a Job Development Investment Grant for the project Thursday morning.
State of play: Fujifilm's plant in southern Wake County is part of a wave of new biotech facilities opening in the Triangle area in recent years.
Around 40,000 people in the Triangle worked in the life sciences industry as of 2022, a significant increase over the past decade, according to research from CBRE.
From 2016 to 2023, lab and R&D space grew from 4.4 million square feet to 9.3 million square feet.
Since 2018, nearly 30 life sciences companies, like Fujifilm Diosynth and Eli Lilly, have invested $8.9 billion in the region and pledged to create nearly 7,000 new jobs.
Editor's note: We've updated this story with details about Fujifilm's local investment.
Get updates delivered to you daily. Free and customizable.
Welcome to NewsBreak, an open platform where diverse perspectives converge. Most of our content comes from established publications and journalists, as well as from our extensive network of tens of thousands of creators who contribute to our platform. We empower individuals to share insightful viewpoints through short posts and comments. It’s essential to note our commitment to transparency: our Terms of Use acknowledge that our services may not always be error-free, and our Community Standards emphasize our discretion in enforcing policies. We strive to foster a dynamic environment for free expression and robust discourse through safety guardrails of human and AI moderation. Join us in shaping the news narrative together.
Comments / 0